Top Interventional Oncology Devices Market Overview and Size

The global interventional oncology devices market is witnessing significant growth as healthcare providers increasingly adopt minimally invasive procedures for cancer diagnosis and treatment. Growing cancer prevalence, technological advancements in image-guided therapies, rising demand for targeted treatments, and improved patient outcomes are accelerating market expansion worldwide.

The global Interventional Oncology Devices Market was valued at approximately USD 2.85 Billion in 2024 and is expected to reach USD 6.75 Billion by 2032, growing at a CAGR of 11.4% during the forecast period (2025–2032).

Interventional oncology combines advanced imaging technologies with minimally invasive procedures to diagnose and treat cancer. Techniques such as tumor ablation, embolization, cryotherapy, and radioembolization are becoming increasingly popular alternatives to conventional surgeries due to shorter recovery times and fewer complications.

Access the Full Report:
https://www.intellectualmarketinsights.com/report/interventional-oncology-devices-market-size/imi-000785

Market Investment Opportunities in the Interventional Oncology Devices Market

The interventional oncology devices market presents substantial investment opportunities due to increasing cancer incidence, advancements in precision medicine, and growing demand for minimally invasive procedures.

Key Investment Areas:

• Tumor ablation technologies
• Radiofrequency and microwave ablation systems
• Cryoablation devices
• Embolization and chemoembolization products
• Radioembolization technologies
• Image-guided navigation systems
• AI-powered oncology treatment planning
• Robotic-assisted interventional oncology procedures
• Advanced catheter and guidewire technologies
• Emerging cancer treatment centers in developing economies

North America currently dominates the market due to advanced healthcare infrastructure and high adoption of innovative cancer therapies, while Asia-Pacific is expected to witness the fastest growth driven by increasing healthcare investments and rising cancer burden.

Key Drivers of the Global Interventional Oncology Devices Market

1. Rising Global Cancer Burden

The increasing incidence of liver cancer, lung cancer, kidney cancer, colorectal cancer, and metastatic tumors is creating significant demand for advanced treatment technologies.

2. Growing Preference for Minimally Invasive Procedures

Patients and healthcare providers increasingly favor minimally invasive treatments due to reduced hospitalization, lower risks, and faster recovery compared to traditional surgeries.

3. Technological Advancements in Image-Guided Therapy

Innovations in CT, MRI, ultrasound, and navigation technologies have significantly improved treatment precision and patient outcomes.

4. Increasing Adoption of Tumor Ablation Techniques

Radiofrequency ablation (RFA), microwave ablation (MWA), and cryoablation have become widely accepted treatment options for localized tumors.

5. Expansion of Specialized Cancer Centers

Growing investments in oncology centers and interventional radiology departments are boosting device adoption globally.

6. Rising Demand for Personalized Cancer Treatment

Precision oncology approaches are encouraging the use of targeted interventional procedures tailored to individual patient needs.

7. Improved Clinical Outcomes

Interventional oncology procedures often provide effective tumor control while preserving healthy tissue, enhancing patient quality of life.

8. Growth in Healthcare Spending

Increased healthcare investments worldwide are facilitating access to advanced oncology technologies.

9. Favorable Reimbursement Policies

Many developed countries are expanding reimbursement coverage for image-guided cancer therapies and minimally invasive treatments.

10. Integration of Artificial Intelligence and Robotics

AI-driven imaging analysis and robotic-assisted interventions are improving procedural accuracy and treatment planning.

Top Companies in the Global Interventional Oncology Devices Market

1. Boston Scientific

Boston Scientific is a global leader in minimally invasive medical technologies and offers a comprehensive portfolio of oncology intervention solutions including embolization products and ablation technologies.

Key Highlights

• Strong global interventional oncology portfolio
• Advanced embolization technologies
• Presence in over 100 countries
• Continuous innovation in image-guided procedures

Category	Details
Founded	1979
Headquarters	Marlborough
Employees	Approximately 50,000+
Revenue	Around USD 14–15 Billion
Industry	Medical Devices
Key Products	Embolization Systems, Oncology Intervention Devices

2. Medtronic

Medtronic is among the world's largest medical technology companies and offers advanced ablation and navigation technologies used in oncology procedures.

Key Highlights

• Extensive minimally invasive treatment portfolio
• Advanced imaging and navigation systems
• Strong R&D investments
• Global healthcare presence

Category	Details
Founded	1949
Headquarters	Dublin
Employees	Approximately 95,000+
Revenue	Around USD 31–33 Billion
Industry	Medical Technology
Key Products	Ablation Systems, Navigation Platforms

3. Johnson & Johnson MedTech

Johnson & Johnson MedTech supports cancer treatment through advanced surgical, imaging, and minimally invasive technologies used in oncology interventions.

Key Highlights

• Strong healthcare ecosystem
• Advanced oncology treatment solutions
• Significant global market reach
• Continuous innovation in cancer care

Category	Details
Founded	1886
Headquarters	New Brunswick
Employees	Approximately 130,000+
Revenue	Around USD 85–90 Billion
Industry	Healthcare & Medical Devices
Key Products	Surgical Oncology Systems, Intervention Technologies

4. AngioDynamics

AngioDynamics specializes in minimally invasive medical technologies and is well known for its oncology-focused ablation systems.

Key Highlights

• Leading tumor ablation technologies
• Focused oncology treatment portfolio
• Strong innovation pipeline
• Specialized interventional solutions

Category	Details
Founded	1988
Headquarters	Latham
Employees	Approximately 1,000+
Revenue	Around USD 300–350 Million
Industry	Medical Devices
Key Products	NanoKnife, Microwave Ablation Systems

5. Merit Medical Systems

Merit Medical develops a broad range of products used in interventional radiology and oncology procedures.

Key Highlights

• Strong catheter and embolization portfolio
• Global interventional radiology presence
• Focus on minimally invasive treatments
• Continuous product expansion

Category	Details
Founded	1987
Headquarters	South Jordan
Employees	Approximately 7,000+
Revenue	Around USD 1.3–1.5 Billion
Industry	Medical Devices
Key Products	Catheters, Embolization Devices

6. Terumo Corporation

Terumo is a leading global medical technology company with strong capabilities in interventional radiology and oncology treatment solutions.

Key Highlights

• Strong vascular intervention portfolio
• Global healthcare footprint
• Advanced catheter technologies
• Growing oncology product range

Category	Details
Founded	1921
Headquarters	Tokyo
Employees	Approximately 30,000+
Revenue	Around USD 7–8 Billion
Industry	Medical Devices
Key Products	Catheters, Guidewires, Embolization Products

7. Cook Medical

Cook Medical is recognized for developing innovative interventional radiology products used extensively in oncology procedures.

Key Highlights

• Specialized intervention technologies
• Strong clinical support programs
• Broad global distribution network
• Focus on patient-centered innovation

Category	Details
Founded	1963
Headquarters	Bloomington
Employees	Approximately 12,000+
Revenue	Privately Held
Industry	Medical Devices
Key Products	Needles, Catheters, Oncology Intervention Devices

8. Varian Medical Systems

Varian, a part of Siemens Healthineers, is a global leader in cancer care technologies and image-guided treatment solutions.

Key Highlights

• Advanced cancer treatment technologies
• Strong imaging capabilities
• Precision oncology focus
• Extensive oncology care ecosystem

Category	Details
Founded	1948
Headquarters	Palo Alto
Employees	Approximately 10,000+
Revenue	Part of Siemens Healthineers
Industry	Oncology Technology
Key Products	Radiation Oncology Systems, Imaging Solutions

9. Becton Dickinson

Becton Dickinson provides advanced biopsy, diagnostic, and interventional technologies supporting oncology treatment pathways.

Key Highlights

• Global healthcare leader
• Advanced biopsy technologies
• Strong diagnostics portfolio
• Significant investment in innovation

Category	Details
Founded	1897
Headquarters	Franklin Lakes
Employees	Approximately 75,000+
Revenue	Around USD 20 Billion
Industry	Medical Technology
Key Products	Biopsy Systems, Diagnostic Devices

10. Stryker Corporation

Stryker continues expanding its minimally invasive treatment technologies and image-guided intervention capabilities.

Key Highlights

• Strong medical technology portfolio
• Advanced imaging and navigation systems
• Growing oncology-related investments
• Global healthcare presence

Category	Details
Founded	1941
Headquarters	Portage
Employees	Approximately 52,000+
Revenue	Around USD 22–23 Billion
Industry	Medical Devices
Key Products	Navigation Systems, Intervention Technologies

Conclusion

The global interventional oncology devices market is experiencing robust growth driven by increasing cancer prevalence, growing adoption of minimally invasive procedures, technological advancements in imaging and ablation technologies, and rising demand for precision medicine. Leading companies such as Boston Scientific, Medtronic, Johnson & Johnson MedTech, AngioDynamics, Terumo, and Merit Medical are investing heavily in innovative treatment platforms to improve clinical outcomes and expand access to advanced cancer care. As healthcare systems continue prioritizing targeted and less invasive therapies, the interventional oncology devices market is expected to witness strong long-term expansion and significant investment opportunities worldwide.